Delivery included to the United States

Circulating Tumor Cells, from Biotech Innovation to Clinical Utility. Part B

Circulating Tumor Cells, from Biotech Innovation to Clinical Utility. Part B - International Review of Cell and Molecular Biology

Hardback (01 May 2025)

Save $6.31

  • RRP $229.01
  • $222.70
Add to basket

Includes delivery to the United States

10+ copies available online - Usually dispatched within 7 days

Publisher's Synopsis

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Circulating Tumor Cells in Lung Cancer: integrating stemness and heterogeneity to improve clinical utility, Multi-omic Features and Clustering Phenotypes of Circulating Tumor Cells Associated with Metastasis and Clinical Outcomes, CTCs in CRC: updates, Proteomics and post-translational modification analysis in CTCs, Latest advances of CTC studies in prostate cancer, and Epigenetics and CTCs: new biomarkers and impact on tumor biology.

Book information

ISBN: 9780443136559
Publisher: Elsevier Science
Imprint: Academic Press
Pub date:
DEWEY: 616.994075
DEWEY edition: 23
Language: English
Number of pages: 277
Weight: 450g
Height: 229mm
Width: 152mm